Product guide · Restricted substance

Nucleon Nutrition GHRP-6 10 mg

Peptide product from Nucleon Nutrition. This guide sets out what the manufacturer states about the composition of Nucleon Nutrition GHRP-6 10 mg, what independent research says about its main ingredient, and the safety and regulatory points that apply. It contains substances that are not authorised as food or medicine in the EU. This guide is educational: it does not recommend use and gives no directions for use.

Educational guide · Sources checked 4 November 2026 · 5 references

Back to the product

Named ingredients: 1
Amounts stated: All
Status: Restricted substance
Evidence summaries: 1

Overview

Manufacturer information

Nucleon Nutrition GHRP-6 10 mg contains GHRP-6: 10 mg, as stated in the product title.

Ingredients & composition

Manufacturer information

Ingredient	Amount
GHRP-6	10 mg (as stated in the product title)

Scientific background

Independent research

GHRP-6

GHRP-6 (growth hormone-releasing hexapeptide) is a synthetic peptide that stimulates growth hormone release through the ghrelin receptor.

Research evidence

Independent research

GHRP-6

In a clinical trial in acute ischaemic stroke, GHRP-6 was studied in combination with epidermal growth factor¹. There are no controlled trials supporting its use for muscle, fat loss or recovery.

Evidence limitations

Independent research

No published study has tested this specific product; the research summarised here concerns the ingredient itself.

GHRP-6

The clinical research concerns a specific medical use, not research-grade products¹.

Safety & potential risks

Independent research

GHRP-6

It can increase appetite and affect blood sugar; safety outside medical supervision is not established. Reviewers describe a "gray market" of unapproved peptides sold directly to consumers outside regulatory oversight, with uncertain purity and safety².

Regulatory status

GIGACULT product information

Contains a peptide that is not authorised as food (including food supplements) or as a medicinal product in the EU. No dosing information for human use is provided.

Regulation and sport

GHRP-6

GHRP-6 is not authorised as a medicine or as a food in the EU³⁴. The World Anti-Doping Agency prohibits non-approved substances and peptide hormones, growth factors and related substances at all times⁵.

Scientific references

Hernández-Bernal F, Subirós-Martínez N, Gutiérrez-Ronquillo JH, et al. Phase III open-label, randomized clinical trial of epidermal growth factor and growth hormone releasing hexapeptide in acute ischemic stroke. J Clin Neurosci. 2026;152:112195. PubMed 42462342
Mendias CL, Awan TM. Safety and efficacy of approved and unapproved peptide therapies for musculoskeletal injuries and athletic performance. Sports Med. 2026;56:1921-1935. PubMed 41966639
Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union. Source
Regulation (EU) 2015/2283 on novel foods. Official Journal of the European Union. Source
World Anti-Doping Agency. The Prohibited List (current edition). Source

Sources checked against PubMed, Crossref or the official publisher on 2026-11-04. Manufacturer information is taken from the product's own data and has not been independently tested.

The product